leisure time -WSS

leisure time

author：entertainment 2025-09-29 16:34:29 - browse：9276

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： CDC overhauls leadership of center that led response to Covid

WSS

Structure Therapeutics oral GLP

After John Oliver segment, STAT readers share their opioid

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Listen: Your guide to Wegovy's blockbuster heart study

After John Oliver segment, STAT readers share their opioid

ASCO Daily Recap: CAR

leisure time

leisure time

Gilead needs Arcellx more than ever

leisure time

Peter Hotez and the public health issue of online harassment

Finland to offer bird flu vaccine to select groups of people, a possible global first

Apple is now the first public company to be valued at $3 trillion

An outdated Medicare rule harms dementia patients with anxiety

Hollywood unions extend contract negotiations for actors

Elevance PBM president out as customers face prescription chaos

Virginia high school admissions case could be legal follow

Stopping antidepressants leads to symptoms for 1 in 6 patients

Heart attack and stroke risk calculators need revising

A new initiative will help leaders fight the next pandemic

explore

Illumina board agrees to spin off Grail, as divestment plans proceed

Pharma budget tightening trickles down to Doximity

Kim Kardashian sparks debate on benefits of full

Elevance PBM president out as customers face prescription chaos

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Covid's long

Wikipedia

leisure time

leisure time

focus